Abstract
We have explored the efficacy of salvage chemotherapy combination, IAPVP-16 (ifosfamide 5 g/m2 on day 1; VP-16 100 mg/m2 on days 1–3; ara-C 1.2 g/m2/12 h on days 1 and 2; methylprednisolone 80 mg/m2 on days 1–5) plus g-csf for pbpc mobilization. this protocol was used in 45 patients with relapsed or refractory lymphoproliferative diseases who underwent 85 leukaphereses. in 41 patients >2 × 106/kg CD34+ cells were obtained after a median of two procedures. The median number of CD34+ cells harvested was 3.2 × 106/kg per apheresis and 8.4 × 106/kg per patient. Seven of 10 patients who had failed previous mobilization attempts achieved more than 2 × 106 CD34+ cells/kg in a maximum of three aphereses. A history of previous mobilization failure and a low platelet count (<150 × 109/l) negatively influenced the CD34+ cell yield in univariate and multivariate analyses. A good correlation was found between the circulating CD34+cells/μl and the CD34+ cells and CFU-GM in the leukaphereses products (r = 0.93 and r = 0.73, P < 0.001), and ⩾17 cd34+cells/μl predicted the achievement of >2 × 106/kg CD34+ cells in a single leukapheresis in more than 90% of cases. IAPVP-16 plus G-CSF may be specially indicated in tandem transplantations or CD34+ selection and in patients who have failed previous mobilization attempts. Bone Marrow Transplantation (2000) 26, 127–132.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gratwohl A, Hermans J, Baldomero H . Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Bone Marrow Transplantation (EBMT) Bone Marrow Transplant 1997 19: 407–419
To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants Bone Marrow Transplant 1992 9: 227–284
Russell NH, McQuaker G, Stainer C et al. Stem cell mobilisation in lymphoproliferative diseases Bone Marrow Transplant 1998 22: 935–940
Bensinger WI, Longin K, Appelbaum F et al. PB stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rh G-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation Br J Haematol 1994 87: 825–831
To LB, Haylock D, Simmons PJ, Juttner C . The biology and clinical uses of blood stem cells Blood 1997 89: 2233–2258
Lopez R, Martino R, Sureda A et al. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience Haematologica 1999 84: 350–355
Garcia J, Martinez E . La criopreservación de precursores hematopoyéticos: su papel en Hematología y Oncología Biol Clin Hematol 1983 5: 99–107
Pike BL, Robinson WA . Human bone marrow colony growth in agar gel J Cell Physiol 1970 76: 77–84
Martinez C, Mateu R, Sureda A et al. Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma Transplant Proc 1995 27: 2355–2356
Martinez C, Sureda A, Martino R et al. Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 μg/m2) after salvage chemotherapy for lymphoma Bone Marrow Transplant 1997 20: 855–858
Lopez R, Martino R, Brunet S et al. Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas Haematologica 1999 84: 911–916
Bender J, To LB, Williams S, Schwartzberg L . Defining a therapeutic dose of peripheral blood stem cells J Hematother 1992 1: 329–334
Haynes AP, Hunter A, McQuaker G et al. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF Bone Marrow Transplant 1995 16: 359–363
Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma J Clin Oncol 1999 17: 3776–3785
Rosenfeld CS, Shadduck RK, Zeigler ZR et al. Cyclophosphamide-mobilized peripheral blood stem cell in patients with lymphoid malignancies Bone Marrow Transplant 1995 15: 433–438
Haas R, Möhle R, Frühauf S et al. Patients characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma Blood 1994 83: 3787–3794
Olivieri A, Offidani M, Ciniero L et al. Optimization of the yield of PBSC for autotransplantation mobilized by high dose chemotherapy and G-CSF: proposal for a mathematical model Bone Marrow Transplant 1994 14: 273–278
Koumakis G, Vassilomanolakis M, Hatzichristou H et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single leukapheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies Bone Marrow Transplant 1996 18: 1065–1072
McQuaker IG, Haynes AP, Stainer C et al. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide Br J Haematol 1997 98: 228–233
Weaver CH, Schwartzberg LS, Birch R et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients Transfusion 1997 37: 896–903
Watts MJ, Sullivan AM, Jamieson E et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma J Clin Oncol 1997 15: 535–546
Armitage S, Hargreaves R, Samson D et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells Bone Marrow Transplant 1997 20: 587–591
Engelhardt M, Winkler J, Waller C et al. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF Bone Marrow Transplant 1997 19: 529–537
Díaz MA, Garcia-Sanchez F, Lillo R et al. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield Haematologica 1999 84: 32–35
Acknowledgements
This study was supported in part by grant FIS 97/0626 from the Fondo de Investigaciones Sanitarias del Ministerio de Sanidad y Consumo and a grant from Fundación Ramón Areces (JS/1997–1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Altés, A., López, R., Martino, R. et al. Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders. Bone Marrow Transplant 26, 127–132 (2000). https://doi.org/10.1038/sj.bmt.1702476
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702476
Keywords
This article is cited by
-
G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT
Bone Marrow Transplantation (2013)
-
The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from kostmann syndrome
International Journal of Hematology (2007)